During the ‘EPSCO’ Council meeting on 21 June, EU Member States are expected to discuss ways (incentives) to improve access to innovative and affordable medicines for patients and national healthcare systems.
These incentives are part of the European Commission’s proposals on pharmaceutical reform to make medicines “more accessible, more affordable and more innovative” (see EUROPE B13388A13).
During a meeting of the Committee of Permanent Representatives of the Member States to the...